Biohaven Pharmaceutical Holding Company Ltd.

NYSE:BHVN

40.42 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -408.168-570.279-213.796-118.668-528.805-240.922-127.19
Depreciation & Amortization 3.3691.3861.3930.072000
Deferred Income Tax -35.5250-5.2610000
Stock Based Compensation 28.787193.55665.63929.554.97216.92513.239
Change In Working Capital 24.613-28.6041.6648.9773.3195.393.975
Accounts Receivables 00-188.158-120.111000
Inventory 00-24.102-37.965000
Accounts Payables 4.8745.9281.0250.2223.3195.393.975
Other Working Capital 19.739-34.532212.899166.831-3.319-5.39-3.975
Other Non Cash Items 55.199106.2524.5214.16293.18321.46615.161
Operating Cash Flow -331.725-297.689-145.84-75.957-377.331-197.141-94.815
Investing Activities:
Investments In Property Plant And Equipment -3.048-41.074-0.938-2.697-2.534-4.165-0.541
Acquisitions Net 0-351.882267.51000
Purchases Of Investments -194.121-263.716-193.295-319.3950-6.375-6.627
Sales Maturities Of Investments 326.9990221.56594.985000
Other Investing Activites 132.878-4-28.27-43.1-1.2500.127
Investing Cash Flow 129.83-304.790.944-2.697-3.784-10.54-7.041
Financing Activities:
Debt Repayment 0-449.130-2.24000
Common Stock Issued 247.12283.804138.05292.242043.9530
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities -35.212932.9230.39562.24434.593296.509209.759
Financing Cash Flow 211.908767.597138.447152.242434.593340.462209.759
Other Information:
Effect Of Forex Changes On Cash -0.4970.429-0.1890.439000
Net Change In Cash 9.514165.547-6.44973.58853.478132.781107.903
Cash At End Of Period 249.72242.60477.05783.506317.727264.249131.468